Neurosurgery, neuro-oncology & endocrinology are rapidly evolving. Our PNI doctors are at the forefront of many developments in the treatment of brain, skull base and pituitary tumors. Some of our recent publications are provided below.
Conditions:
Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.
Marzese DM, Scolyer RA, Huynh JL, Huang SK, Hirose H, Chong KK, Kiyohara E, Wang J, Kawas NP, Donovan NC, Hata K, Wilmott JS, Murali R, Buckland ME, Shivalingam B, Thompson JF, Morton DL, Kelly DF, Hoon DS. Hum Mol Genet. 2014 Jan 1;23(1):226-38. Epub 2013 Sep 6. PMID:24014427
Learn MoreProspective validation of a patient-reported nasal quality-of-life tool for endonasal skull base surgery: The Anterior Skull Base Nasal Inventory-12.
Little AS, Kelly D, Milligan J, Griffiths C, Rosseau G, Prevedello DM, Carrau R, Jahnke H, Chaloner C, O'Leary J, Chapple K, Nakaji P, White WL.. J Neurosurg. 2013 May 10. [Epub ahead of print] PMID: 23662829.
Learn MoreNeuronavigation in endonasal pituitary and skull base surgery using an autoregistration mask without head fixation: an assessment of accuracy and practicality.
McLaughlin N, Carrau, RL, Kassam AB, Kelly DF. J Neurol Surg A Cent Eur Neurosurg. 2012 Nov;73(6):351-7.
Learn MoreCorticospinal tractography as a prognosticator for motor improvement after brainstem cavernoma resection.
McLaughlin N, Kelly DF: Br J Neurosurg. 2013 Feb;27(1):108-10.
Learn MoreSide-cutting aspiration device for endoscopic and microscopic tumor removal.
McLaughlin N, Ditzel Filho LF, Prevedello DM, Kelly DF, Carrau RL, Kassam AB. J Neurol Surg B Skull Base. 2012 Feb;73(1):11-20.
Learn MoreEndonasal management of sellar arachnoid cysts: simple cyst obliteration technique.
McLaughlin N, Vandergrift A, Ditzel Filho LF, Shahlaie K, Eisenberg AA, Carrau RL, Cohan P, Kelly DF. J Neurosurg. 2012 Apr;116(4):728-40.
Learn MoreTransnasal, transfacial, anterior skull base resection of olfactory neuroblastoma.
Nabili V, Kelly DF, Fatemi N, St John M, Calcaterra TC, Abemayor E. Am J Otolaryngol. 2011 Jul-Aug;32(4):279-85.
Learn MoreManagement of Cushing’s disease after failed surgery–a review.
McLaughlin N, Kassam AB, Prevedello DM, Kelly DF. Can J Neurol Sci. 2011 Jan;38(1):12-21.
Learn MoreThe role of outcomes data for assessing the expertise of a pituitary surgeon.
Shahlaie K, McLaughlin N, Kassam AB, Kelly DF. Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):369-76.
Learn MoreEndonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas.
de Paiva Neto MA, Vandergrift A, Fatemi N, Gorgulho AA, Desalles AA, Cohan P, Wang C, Swerdloff R, Kelly DF. Clin Endocrinol (Oxf). 2010 Apr;72(4):512-9.
Learn MorePituitary hormonal loss and recovery after transsphenoidal adenoma removal.
Fatemi N, Dusick JR, Mattozo C, McArthur DL, Cohan P, Boscardin J, Wang C, Swerdloff RS, Kelly DF. Neurosurgery. 2008 Oct;63(4):709-18; discussion 718-9.
Learn MorePrimary sphenoid sinus neoplasms: a report of four cases with common clinical presentation treated with transsphenoidal surgery and adjuvant therapies.
Esposito F, Kelly DF, Vinters HV, DeSalles AA, Sercarz J, Gorgulhos AA. J Neurooncol. 2006 Feb;76(3):299-306.
Learn MoreVascular injury and transsphenoidal surgery.
Oskouian RJ, Kelly DF, Laws ER Jr. Front Horm Res. 2006;34:256-78.
Learn MoreThe extended direct endonasal transsphenoidal approach for nonadenomatous suprasellar tumors.
Dusick JR, Esposito F, Kelly DF, Cohan P, DeSalles A, Becker DP, Martin NA. J Neurosurg. 2005 May;102(5):832-41.
Learn MoreEndonasal transsphenoidal transclival removal of prepontine epidermoid tumors: technical note.
Esposito F, Becker DP, Villablanca JP, Kelly DF. Neurosurgery. 2005 Apr;56(2 Suppl):E443; discussion E443.
Learn MoreSymptomatic Rathke’s cleft cysts: a report of 24 cases.
Cohan P, Foulad A, Esposito F, Martin NA, Kelly DF. J Endocrinol Invest. 2004 Nov;27(10):943-8.
Learn MoreEndonasal transsphenoidal approach for pituitary adenomas and other sellar lesions: an assessment of efficacy, safety, and patient impressions.
Zada G, Kelly DF, Cohan P, Wang C, Swerdloff R. J Neurosurg. 2003 Feb;98(2):350-8.
Learn MoreSellar Masses that Present with Severe Hyponatremia
Bordo G, Kelly K, McLaughlin N, Miyamoto S, Duong HT, Eisenberg A, Chaloner C, Cohan P, Barkhoudarian G, Kelly DF. Endocr Pract. 2014 Nov;20(11):1178-86. PMID: 25100360
Learn MoreThe expanding role of the endonasal endoscopic approach in pituitary and skull base surgery: A 2014 perspective.
Lobo B, Heng A, Barkhoudarian G, Griffiths CF, Kelly DF. Surg Neurol Int. 2015 May 20; Review. PMID: 26015870
Learn MoreEvolution of minimally invasive approaches to the sella and parasellar region.
Louis RG, Eisenberg A, Barkhoudarian G, Griffiths C, Kelly DF. Int Arch Otorhinolaryngol. 2014 Oct; PMID: 25992138
Learn MoreThe Supraorbital Endoscopic Approach for Tumors
Wilson DA, Duong H, Teo C, Kelly DF. World Neurosurg. 2013 Feb 5. [Epub ahead of print]
Learn MorePituitary Centers of Excellence
McLaughlin N, Laws ER, Oyesiku NM, Katznelson L, Kelly DF. Neurosurgery. 2012 Aug 16. [Epub ahead of print]
Learn MoreThe supraorbital approach for recurrent or residual suprasellar tumors.
McLaughlin N, Ditzel Filho LF, Shahlaie K, Solari D, Kassam AB, Kelly DF. Minim Invasive Neurosurg. 2011 Aug;54(4):155-61.
Learn MoreEndonasal vs supraorbital keyhole removal of craniopharyngiomas and tuberculum sellae meningiomas.
Fatemi N, Dusick JR, de Paiva Neto MA, Malkasian D, Kelly DF. Neurosurgery. 2009 May;64(5 Suppl 2):269-84; discussion 284-6.
Learn MorePituitary function after endonasal surgery for nonadenomatous parasellar tumors: Rathke’s cleft cysts, craniopharyngiomas, and meningiomas.
Dusick JR, Fatemi N, Mattozo C, McArthur D, Cohan P, Wang C, Swerdloff RS, Kelly DF. Surg Neurol. 2008 Nov;70(5):482-90; discussion 490-1.
Learn MoreThe endonasal microscopic approach for pituitary adenomas and other parasellar tumors: a 10-year experience.
Fatemi N, Dusick JR, de Paiva Neto MA, Kelly DF. Neurosurgery. 2008 Oct;63(4 Suppl 2):244-56; discussion 256.
Learn MoreThe role of the endoscope in the transsphenoidal management of cystic lesions of the sellar region.
Cavallo LM, Prevedello D, Esposito F, Laws ER Jr, Dusick JR, Messina A, Jane JA Jr, Kelly DF, Cappabianca P. Neurosurg Rev. 2008 Jan;31(1):55-64; discussion 64.
Learn MoreGraded repair of cranial base defects and cerebrospinal fluid leaks in transsphenoidal surgery.
Esposito F, Dusick JR, Fatemi N, Kelly DF. Neurosurgery. 2007 Apr;60(4 Suppl 2):295-303; discussion 303-4.
Learn MoreRole of Endoscopic Skull Base and Keyhole Surgery for Pituitary and Parasellar Tumors Impacting Vision
Kelly DF, Griffiths CF, Takasumi Y, Rhee J, Barkhoudarian G, Krauss HR. J Neuroophthalmol. 2015 Dec;35(4):335-41. PMID: 26576016
Learn MoreThe expanding role of the endonasal endoscopic approach in pituitary and skull base surgery: A 2014 perspective.
Lobo B, Heng A, Barkhoudarian G, Griffiths CF, Kelly DF. Surg Neurol Int. 2015 May 20; Review. PMID: 26015870
Learn MoreEvolution of minimally invasive approaches to the sella and parasellar region.
Louis RG, Eisenberg A, Barkhoudarian G, Griffiths C, Kelly DF. Int Arch Otorhinolaryngol. 2014 Oct; PMID: 25992138
Learn MoreThe endonasal microscopic approach for pituitary adenomas and other parasellar tumors: a 10-year experience.
Fatemi N, Dusick JR, de Paiva Neto MA, Kelly DF. Neurosurgery. 2008 Oct;63(4 Suppl 2):244-56; discussion 256.
Learn MoreEndonasal microscopic removal of clival chordomas.
Fatemi N, Dusick JR, Gorgulho AA, Mattozo CA, Moftakhar P, De Salles AA, Kelly DF. Surg Neurol. 2008 Apr;69(4):331-8.
Learn MoreMaintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z. JAMA. 2015 Dec 15;314(23):2535-2543.
Learn MorePPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244
Elinzano H, Glantz M, Mrugala M, Kesari S, Piccioni DE, Kim L, Pan E, Yunus S, Coyle T, Timothy K, Evans D, Mantripragada K, Boxerman J, DiPetrillo T, Donahue JE, Hebda N, Mitchell KM, Rosati KL, Safran H. Am J Clin Oncol. 2015 Dec 9.
Learn MoreMultiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma.
Tsigelny IF, Mukthavaram R, Kouznetsova VL, Chao Y, Babic I, Nurmemmedov E, Pastorino S, Jiang P, Calligaris D, Agar N, Scadeng M, Pingle SC, Wrasidlo W, Makale MT, Kesari S. Oncotarget. 2015 Oct 30.
Learn MoreA randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study.
Robins HI, Zhang P, Gilbert MR, Chakravarti A, de Groot JF, Grimm SA, Wang F, Lieberman FS, Krauze A, Trotti AM, Mohile N, Kee AY, Colman H, Cavaliere R, Kesari S, Chmura SJ, Mehta M. J Neurooncol. 2015 Oct 27.
Learn MoreEffect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres
Mukthavaram R, Ouyang X, Saklecha R, Jiang P, Nomura N, Pingle SC, Guo F, Makale M, Kesari S. J Transl Med. 2015 Aug 18;13:269.
Learn MoreMolecular profiling of gliomas: potential therapeutic implications
Alentorn A, Duran-Peña A, Pingle SC, Piccioni DE, Idbaih A, Kesari S. Expert Rev Anticancer Ther. 2015 Aug;15(8):955-62.
Learn MorePlexin-B2 promotes invasive growth of malignant glioma
Le AP, Huang Y, Pingle SC, Kesari S, Wang H, Yong RL, Zou H, Friedel RH. Oncotarget. 2015 Mar 30;6(9):7293-304.
Learn MoreGlucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes
Nozawa A, Rivandi AH, Kanematsu M, Hoshi H, Piccioni D, Kesari S, Hoh CK. Nucl Med Commun. 2015 Jun;36(6):573-81.
Learn MoreHierarchical control of coherent gene clusters defines the molecular mechanisms of glioblastoma
Tsigelny IF, Kouznetsova VL, Jiang P, Pingle SC, Kesari S. Mol Biosyst. 2015 Apr;11(4):1012-28.
Learn MorePhase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma
Schiff D, Kesari S, de Groot J, Mikkelsen T, Drappatz J, Coyle T, Fichtel L, Silver B, Walters I, Reardon D. Invest New Drugs. 2015 Feb;33(1):247-53.
Learn MoreRetrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomas
van Vugt VA, Piccioni DE, Brown BD, Brown T, Saria MG, Juarez T, Kesari S. CNS Oncol. 2014 Jul;3(4):257-65.
Learn MoreProstate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases
Nomura N, Pastorino S, Jiang P, Lambert G, Crawford JR, Gymnopoulos M, Piccioni D, Juarez T, Pingle SC, Makale M, Kesari S. Cancer Cell Int. 2014 Mar 20;14(1):26.
Learn MoreSellar and supra-sellar glioblastoma masquerading as a pituitary macroadenoma
Mahta A, Buhl R, Huang H, Jansen O, Kesari S, Ulmer S. Neurol Sci. 2013 Apr;34(4):605-7. PMID: 22569569
Cell phones and glioma risk: a review of the evidence
Corle C, Makale M, Kesari S. J Neurooncol. 2012 Jan;106(1):1-13. PMID: 21853424
Learn MoreCorticosteroids in brain cancer patients: benefits and pitfalls
Dietrich J, Rao K, Pastorino S, Kesari S. Expert Rev Clin Pharmacol. 2011 Mar;4(2):233-42. PMID: 21666852
Learn MoreLeptomeningeal metastasis in breast cancer – a systematic review
Scott BJ, Oberheim-Bush NA, Kesari S. Oncotarget. 2015 Nov 2.
Learn MoreA phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer
Jackman DM, Cioffredi LA, Jacobs L, Sharmeen F, Morse LK, Lucca J, Plotkin SR, Marcoux PJ, Rabin MS, Lynch TJ, Johnson BE, Kesari S. Oncotarget. 2015 Feb 28;6(6):4527-36.
Learn MoreConcurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study
Scott BJ, van Vugt VA, Rush T, Brown T, Chen CC, Carter BS, Schwab R, Fanta P, Helsten T, Bazhenova L, Parker B, Pingle S, Saria MG, Brown BD, Piccioni DE, Kesari S. J Neurooncol. 2014 Sep;119(2):361-8.
Learn MoreNovel approaches to treating leptomeningeal metastases
Grewal J, Saria MG, Kesari S. J Neurooncol. 2012 Jan;106(2):225-34. PMID: 21874597
Learn MoreDurable remission of leptomeningeal metastases from hormone-responsive prostate cancer
Zhang M, Mahta A, Kim RY, Akar S, Kesari S. Med Oncol. 2012 Jun;29(2):806-8 PMID: 21424585
Learn MoreEndonasal Endoscopic Management of Parasellar and Cavernous Sinus Meningiomas
Lobo B, Zhang X, Barkhoudarian G, Griffiths CF, Kelly DF. Neurosurg Clin N Am. 2015 Jul;26(3):389-401. doi: 10.1016/j.nec.2015.03.004. Epub 2015 May 7. Review. PMID: 26141358
Learn MoreRole of Endoscopic Skull Base and Keyhole Surgery for Pituitary and Parasellar Tumors Impacting Vision
Kelly DF, Griffiths CF, Takasumi Y, Rhee J, Barkhoudarian G, Krauss HR. J Neuroophthalmol. 2015 Dec;35(4):335-41. PMID: 26576016
Learn MoreThe expanding role of the endonasal endoscopic approach in pituitary and skull base surgery: A 2014 perspective.
Lobo B, Heng A, Barkhoudarian G, Griffiths CF, Kelly DF. Surg Neurol Int. 2015 May 20; Review. PMID: 26015870
Learn MoreEvolution of minimally invasive approaches to the sella and parasellar region.
Louis RG, Eisenberg A, Barkhoudarian G, Griffiths C, Kelly DF. Int Arch Otorhinolaryngol. 2014 Oct; PMID: 25992138
Learn MoreThe Supraorbital Endoscopic Approach for Tumors
Wilson DA, Duong H, Teo C, Kelly DF. World Neurosurg. 2013 Feb 5. [Epub ahead of print]
Learn MoreThe endonasal microscopic approach for pituitary adenomas and other parasellar tumors: a 10-year experience.
Fatemi N, Dusick JR, de Paiva Neto MA, Kelly DF. Neurosurgery. 2008 Oct;63(4 Suppl 2):244-56; discussion 256.
Learn MoreThe role of the endoscope in the transsphenoidal management of cystic lesions of the sellar region.
Cavallo LM, Prevedello D, Esposito F, Laws ER Jr, Dusick JR, Messina A, Jane JA Jr, Kelly DF, Cappabianca P. Neurosurg Rev. 2008 Jan;31(1):55-64; discussion 64.
Learn MoreGraded repair of cranial base defects and cerebrospinal fluid leaks in transsphenoidal surgery.
Esposito F, Dusick JR, Fatemi N, Kelly DF. Neurosurgery. 2007 Apr;60(4 Suppl 2):295-303; discussion 303-4.
Learn MoreRadiation-associated meningiomas in children: clinical, pathological, and cytogenetic characteristics with a critical review of the literature
Elbabaa SK, Gokden M, Crawford JR, Kesari S, Saad AG. J Neurosurg Pediatr. 2012 Oct;10(4):281-90 PMID: 22900483
Learn MoreEndoscopic and Gravity-Assisted Resection of Medial Temporo-occipital Lesions Through a Supracerebellar Transtentorial Approach: Technical Notes With Case Illustrations
Villanueva P, Louis RG, Cutler AR, Wei H, Sale D, Duong HT, Barkhoudarian G, Kelly DF. Neurosurgery. 2015 Aug 14. PMID: 26280113
Learn MoreEpigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives
Marzese DM, Witz IP, Kelly DF, Hoon DS. Epigenomics. 2015 Dec 7. [Epub ahead of print] PMID: 26638944
Learn MoreBrain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome
Marzese DM, Liu M, Huynh JL, Hirose H, Donovan NC, Huynh KT, Kiyohara E, Chong K, Cheng D, Tanaka R, Wang J, Morton DL, Barkhoudarian G, Kelly DF, Hoon DS. Pigment Cell Melanoma Res. 2015 Jan;28(1):82-93. doi: 10.1111/pcmr.12307. Epub 2014 Sep 30. PMID: 25169209
Learn MoreDNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations
Marzese DM, Scolyer RA, Roqué M, Vargas-Roig LM, Huynh JL, Wilmott JS, Murali R, Buckland ME, Barkhoudarian G, Thompson JF, Morton DL, Kelly DF, Hoon DS.Neuro Oncol. 2014 Nov;16(11):1499-509. PMID: 24968695
Learn MoreEpigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.
Marzese DM, Scolyer RA, Huynh JL, Huang SK, Hirose H, Chong KK, Kiyohara E, Wang J, Kawas NP, Donovan NC, Hata K, Wilmott JS, Murali R, Buckland ME, Shivalingam B, Thompson JF, Morton DL, Kelly DF, Hoon DS. Hum Mol Genet. 2014 Jan 1;23(1):226-38. Epub 2013 Sep 6. PMID:24014427
Learn MoreSupraorbital Eyebrow Craniotomy for Removal of Intraaxial Frontal Brain Tumors.
Ditzel Filho LF, McLaughlin N, Bresson D, Solari D, Kassam AB, Kelly DF.: A Technical Note. World Neurosurg. 2013 Jan 23. [Epub ahead of print]
Learn MoreThe Supraorbital Endoscopic Approach for Tumors
Wilson DA, Duong H, Teo C, Kelly DF. World Neurosurg. 2013 Feb 5. [Epub ahead of print]
Learn MoreStrategies for overcoming the blood-brain barrier for the treatment of brain metastases
Hu J, Kesari S. CNS Oncol. 2013 Jan;2(1):87-98. PMID: 25054359
Learn MoreCurrent Perspectives in the Management of Brain Metastases
Saria MG, Piccioni D, Carter J, Orosco H, Turpin T, Kesari S. Clin J Oncol Nurs. 2015 Aug;19(4):475-9. PMID: 26207714
Learn MoreSellar Masses that Present with Severe Hyponatremia
Bordo G, Kelly K, McLaughlin N, Miyamoto S, Duong HT, Eisenberg A, Chaloner C, Cohan P, Barkhoudarian G, Kelly DF. Endocr Pract. 2014 Nov;20(11):1178-86. PMID: 25100360
Learn MoreRole of Endoscopic Skull Base and Keyhole Surgery for Pituitary and Parasellar Tumors Impacting Vision
Kelly DF, Griffiths CF, Takasumi Y, Rhee J, Barkhoudarian G, Krauss HR. J Neuroophthalmol. 2015 Dec;35(4):335-41. PMID: 26576016
Learn MoreImpact of selective pituitary gland incision or resection on hormonal function after adenoma or cyst resection.
Barkhoudarian G, Cutler AR, Yost S, Lobo B, Eisenberg A, Kelly DF. Pituitary. 2015 Jun 27.
PMID: 26115709
Predictors of sinonasal quality of life and nasal morbidity after fully endoscopic transsphenoidal surgery.
Little AS, Kelly D, Milligan J, Griffiths C, Prevedello DM, Carrau RL, Rosseau G, Barkhoudarian G, Otto BA, Jahnke H, Chaloner C, Jelinek KL, Chapple K, White WL. J Neurosurg. 2015 Jun; Epub 2015 Apr 3. PMID: 25839931
Learn MoreComparison of sinonasal quality of life and health status in patients undergoing microscopic and endoscopic transsphenoidal surgery for pituitary lesions: a prospective cohort study.
Little AS, Kelly DF, Milligan J, Griffiths C, Prevedello DM, Carrau RL, Rosseau G, Barkhoudarian G, Jahnke H, Chaloner C, Jelinek KL, Chapple K, White WL. J Neurosurg. 2015 Apr 17, PMID: 25884256
Learn MoreThe expanding role of the endonasal endoscopic approach in pituitary and skull base surgery: A 2014 perspective.
Lobo B, Heng A, Barkhoudarian G, Griffiths CF, Kelly DF. Surg Neurol Int. 2015 May 20; Review. PMID: 26015870
Learn MoreEvolution of minimally invasive approaches to the sella and parasellar region.
Louis RG, Eisenberg A, Barkhoudarian G, Griffiths C, Kelly DF. Int Arch Otorhinolaryngol. 2014 Oct; PMID: 25992138
Learn MoreChemotherapy-induced regression of an adrenocorticotropin-secreting pituitary carcinoma accompanied by secondary adrenal insufficiency.
Cornell RF, Kelly DF, Bordo G, Carroll TB, Duong HT, Kim J, Takasumi Y, Thomas JP, Wong YL, Findling JW. Case Rep Endocrinol. Epub 2013 Dec 22. PMID: 24455332
Learn MoreThe value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery.
McLaughlin N, Eisenberg A, Cohan P, Chaloner C, Kelly DF. J Neurosurgery. 2013 Mar; 118(3):613-20.
Learn MorePituitary Centers of Excellence
McLaughlin N, Laws ER, Oyesiku NM, Katznelson L, Kelly DF. Neurosurgery. 2012 Aug 16. [Epub ahead of print]
Learn MoreEarly morning cortisol levels as predictors of short and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke’s cleft cysts.
McLaughlin N, Cohan P, Barnett P, Eisenberg A, Chaloner C, Kelly DF. World Neurosurg. 2012 Aug 14. [Epub ahead of print]
Learn MoreEndonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas.
de Paiva Neto MA, Vandergrift A, Fatemi N, Gorgulho AA, Desalles AA, Cohan P, Wang C, Swerdloff R, Kelly DF. Clin Endocrinol (Oxf). 2010 Apr;72(4):512-9.
Learn MoreThe endonasal microscopic approach for pituitary adenomas and other parasellar tumors: a 10-year experience.
Fatemi N, Dusick JR, de Paiva Neto MA, Kelly DF. Neurosurgery. 2008 Oct;63(4 Suppl 2):244-56; discussion 256.
Learn MoreThe role of the endoscope in the transsphenoidal management of cystic lesions of the sellar region.
Cavallo LM, Prevedello D, Esposito F, Laws ER Jr, Dusick JR, Messina A, Jane JA Jr, Kelly DF, Cappabianca P. Neurosurg Rev. 2008 Jan;31(1):55-64; discussion 64.
Learn MoreAvoidance of carotid artery injuries in transsphenoidal surgery with the Doppler probe and micro-hook blades.
Dusick JR, Esposito F, Malkasian D, Kelly DF. Neurosurgery. 2007 Apr;60(4 Suppl 2):322-8; discussion 328-9.
Learn MoreGraded repair of cranial base defects and cerebrospinal fluid leaks in transsphenoidal surgery.
Esposito F, Dusick JR, Fatemi N, Kelly DF. Neurosurgery. 2007 Apr;60(4 Suppl 2):295-303; discussion 303-4.
Learn MoreTranssphenoidal surgery for Cushing’s disease: a review of success rates, remission predictors, management of failed surgery, and Nelson’s Syndrome.
Kelly DF. Neurosurg Focus. 2007;23(3):E5.
Learn MoreSuboptimal sphenoid and sellar exposure: a consistent finding in patients treated with repeat transsphenoidal surgery for residual endocrine-inactive macroadenomas.
Mattozo CA, Dusick JR, Esposito F, Mora H, Cohan P, Malkasian D, Kelly DF. Neurosurgery. 2006 May;58(5):857-65; discussion 857-65.
Learn MoreEndonasal transsphenoidal surgery: the patient’s perspective-survey results from 259 patients.
Dusick JR, Esposito F, Mattozo CA, Chaloner C, McArthur DL, Kelly DF. Surg Neurol. 2006 Apr;65(4):332-41, discussion 341-2.
Learn MoreClinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease.
Esposito F, Dusick JR, Cohan P, Moftakhar P, McArthur D, Wang C, Swerdloff RS, Kelly DF. J Clin Endocrinol Metab. 2006 Jan;91(1):7-13.
Learn MoreSellar Masses that Present with Severe Hyponatremia
Bordo G, Kelly K, McLaughlin N, Miyamoto S, Duong HT, Eisenberg A, Chaloner C, Cohan P, Barkhoudarian G, Kelly DF. Endocr Pract. 2014 Nov;20(11):1178-86. PMID: 25100360
Learn MoreImpact of selective pituitary gland incision or resection on hormonal function after adenoma or cyst resection.
Barkhoudarian G, Cutler AR, Yost S, Lobo B, Eisenberg A, Kelly DF. Pituitary. 2015 Jun 27.
PMID: 26115709
The expanding role of the endonasal endoscopic approach in pituitary and skull base surgery: A 2014 perspective.
Lobo B, Heng A, Barkhoudarian G, Griffiths CF, Kelly DF. Surg Neurol Int. 2015 May 20; Review. PMID: 26015870
Learn MorePituitary Centers of Excellence
McLaughlin N, Laws ER, Oyesiku NM, Katznelson L, Kelly DF. Neurosurgery. 2012 Aug 16. [Epub ahead of print]
Learn MoreEarly morning cortisol levels as predictors of short and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke’s cleft cysts.
McLaughlin N, Cohan P, Barnett P, Eisenberg A, Chaloner C, Kelly DF. World Neurosurg. 2012 Aug 14. [Epub ahead of print]
Learn MoreThe role of outcomes data for assessing the expertise of a pituitary surgeon.
Shahlaie K, McLaughlin N, Kassam AB, Kelly DF. Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):369-76.
Learn MorePituitary function after endonasal surgery for nonadenomatous parasellar tumors: Rathke’s cleft cysts, craniopharyngiomas, and meningiomas.
Dusick JR, Fatemi N, Mattozo C, McArthur D, Cohan P, Wang C, Swerdloff RS, Kelly DF. Surg Neurol. 2008 Nov;70(5):482-90; discussion 490-1.
Learn MoreThe endonasal microscopic approach for pituitary adenomas and other parasellar tumors: a 10-year experience.
Fatemi N, Dusick JR, de Paiva Neto MA, Kelly DF. Neurosurgery. 2008 Oct;63(4 Suppl 2):244-56; discussion 256.
Learn MoreThe role of the endoscope in the transsphenoidal management of cystic lesions of the sellar region.
Cavallo LM, Prevedello D, Esposito F, Laws ER Jr, Dusick JR, Messina A, Jane JA Jr, Kelly DF, Cappabianca P. Neurosurg Rev. 2008 Jan;31(1):55-64; discussion 64.
Learn MoreGraded repair of cranial base defects and cerebrospinal fluid leaks in transsphenoidal surgery.
Esposito F, Dusick JR, Fatemi N, Kelly DF. Neurosurgery. 2007 Apr;60(4 Suppl 2):295-303; discussion 303-4.
Learn MoreSymptomatic Rathke’s cleft cysts: a report of 24 cases.
Cohan P, Foulad A, Esposito F, Martin NA, Kelly DF. J Endocrinol Invest. 2004 Nov;27(10):943-8.
Learn MorePrevalence of pituitary hormone dysfunction, metabolic syndrome and impaired quality of life in retired professional football players: a prospective study.
Kelly DF, Chaloner C, Evans D, Matthews A, Cohan P, Wang C, Swerdloff R, Sim MS, Lee J, Wright MJ, Kernan CL, Barkhoudarian G, Yuen K, Guskiewicz KK. J Neurotrauma. 2014 Feb 19. [Epub ahead of print]
Learn MorePathophysiology of hypopituitarism in the setting of brain injury.
Dusick JR, Wang C, Cohan P, Swerdloff R, Kelly DF. Pituitary. 2012 Mar;15(1):2-9.
Learn MoreChronic hypopituitarism after traumatic brain injury: risk assessment and relationship to outcome.
Bavisetty S, Bavisetty S, McArthur DL, Dusick JR, Wang C, Cohan P, Boscardin WJ, Swerdloff R, Levin H, Chang DJ, Muizelaar JP, Kelly DF. Neurosurgery. 2008 May;62(5):1080-93; discussion 1093-4.
Learn MoreNeurobehavioral and quality of life changes associated with growth hormone insufficiency after complicated mild, moderate, or severe traumatic brain injury.
Kelly DF, McArthur DL, Levin H, Swimmer S, Dusick JR, Cohan P, Wang C, Swerdloff R. J Neurotrauma. 2006 Jun;23(6):928-42.
Learn MoreAcute secondary adrenal insufficiency after traumatic brain injury: a prospective study.
Cohan P, Wang C, McArthur DL, Cook SW, Dusick JR, Armin B, Swerdloff R, Vespa P, Muizelaar JP, Cryer HG, Christenson PD, Kelly DF. Crit Care Med. 2005 Oct;33(10):2358-66
Learn MoreHypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report.
Kelly DF, Gonzalo IT, Cohan P, Berman N, Swerdloff R, Wang C. J Neurosurg. 2000 Nov;93(5):743-52.
Learn MoreTreatment Approaches & Novel Therapies:
Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?
Wagner SC, Ichim TE, Ma H, Szymanski J, Perez JA, Lopez J, Bogin V, Patel AN, Marincola FM, Kesari S. J Transl Med. 2015 Oct 29;13:340.
Learn MoreOvercoming tumor immune evasion with an unique arbovirus
Lyday B, Chen T, Kesari S, Minev B. J Transl Med. 2015 Jan 16;13:3.
Learn MoreInduction of tumor inhibitory anti-angiogenic response through immunization with interferon Gamma primed placental endothelial cells: ValloVax™
Ichim TE, Li S, Ma H, Yurova YV, Szymanski JS, Patel AN, Kesari S, Min WP, Wagner SC. J Transl Med. 2015 Mar 14;13:90.
Learn MoreBevacizumab: radiation combination produces restricted diffusion on brain MRI
Hesselink JR, Barkovich MJ, Seibert TM, Farid N, Muller KA, Murphy KT, Kesari S. CNS Oncol. 2014;3(5):329-35.
Learn MoreChemotherapy-induced regression of an adrenocorticotropin-secreting pituitary carcinoma accompanied by secondary adrenal insufficiency.
Cornell RF, Kelly DF, Bordo G, Carroll TB, Duong HT, Kim J, Takasumi Y, Thomas JP, Wong YL, Findling JW. Case Rep Endocrinol. Epub 2013 Dec 22. PMID: 24455332
Learn MoreNanoparticles: Recovery of Drug Delivery Nanoparticles from Human Plasma Using an Electrokinetic Platform Technology
Ibsen S, Sonnenberg A, Schutt C, Mukthavaram R, Yeh Y, Ortac I, Manouchehri S, Kesari S, Esener S, Heller MJ. Small. 2015 Oct;11(38):4990.
Learn MoreCyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics
Kato S, Schwaederle M, Daniels GA, Piccioni D, Kesari S, Bazhenova L, Shimabukuro K, Parker BA, Fanta P, Kurzrock R. Cell Cycle. 2015;14(8):1252-9.
Learn MoreMitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction
Fogal V, Babic I, Chao Y, Pastorino S, Mukthavaram R, Jiang P, Cho YJ, Pingle SC, Crawford JR, Piccioni DE, Kesari S. Oncotarget. 2015 Jan 20;6(2):1157-70.
Learn MoreA novel bioavailable BH3 mimetic efficiently inhibits colon cancer via cascade effects of mitochondria
Wang X, Zhang C, Yan X, Lan B, Wang J, Wei C, Cao X, Wang R, Yao J, Zhou T, Zhou M, Liu Q, Jiang B, Jiang P, Kesari S, Lin X, Guo F. Clin Cancer Res. 2015 Oct 29
Learn MoreIn vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells
Jiang P, Mukthavaram R, Chao Y, Nomura N, Bharati IS, Fogal V, Pastorino S, Teng D, Cong X, Pingle SC, Kapoor S, Shetty K, Aggrawal A, Vali S, Abbasi T, Chien S, Kesari S. Br J Cancer. 2014 Oct 14;111(8):1562-71.
Learn MoreTargeting and depletion of circulating leukocytes and cancer cells by lipophilic antibody-modified erythrocytes
Mukthavaram R, Shi G, Kesari S, Simberg D. J Control Release. 2014 Jun 10;183:146-53.
Learn MoreNovel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs
Jiang P, Mukthavaram R, Chao Y, Bharati IS, Fogal V, Pastorino S, Cong X, Nomura N, Gallagher M, Abbasi T, Vali S, Pingle SC, Makale M, Kesari S. J Transl Med. 2014 Jan 17;12:13.
Learn MorePTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression
Muh CR, Joshi S, Singh AR, Kesari S, Durden DL, Makale MT. J Neurooncol. 2014 Jan;116(1):89-97.
Learn MoreNanoparticles: Recovery of Drug Delivery Nanoparticles from Human Plasma Using an Electrokinetic Platform Technology
Ibsen S, Sonnenberg A, Schutt C, Mukthavaram R, Yeh Y, Ortac I, Manouchehri S, Kesari S, Esener S, Heller MJ. Small. 2015 Oct;11(38):4990.
Learn MoreCyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics
Kato S, Schwaederle M, Daniels GA, Piccioni D, Kesari S, Bazhenova L, Shimabukuro K, Parker BA, Fanta P, Kurzrock R. Cell Cycle. 2015;14(8):1252-9.
Learn MoreMitochondrial p32 is upregulated in Myc expressing brain cancers and mediates glutamine addiction
Fogal V, Babic I, Chao Y, Pastorino S, Mukthavaram R, Jiang P, Cho YJ, Pingle SC, Crawford JR, Piccioni DE, Kesari S. Oncotarget. 2015 Jan 20;6(2):1157-70.
Learn MoreA novel bioavailable BH3 mimetic efficiently inhibits colon cancer via cascade effects of mitochondria
Wang X, Zhang C, Yan X, Lan B, Wang J, Wei C, Cao X, Wang R, Yao J, Zhou T, Zhou M, Liu Q, Jiang B, Jiang P, Kesari S, Lin X, Guo F. Clin Cancer Res. 2015 Oct 29
Learn MoreIn vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells
Jiang P, Mukthavaram R, Chao Y, Nomura N, Bharati IS, Fogal V, Pastorino S, Teng D, Cong X, Pingle SC, Kapoor S, Shetty K, Aggrawal A, Vali S, Abbasi T, Chien S, Kesari S. Br J Cancer. 2014 Oct 14;111(8):1562-71.
Learn MoreEndonasal Endoscopic Management of Parasellar and Cavernous Sinus Meningiomas
Lobo B, Zhang X, Barkhoudarian G, Griffiths CF, Kelly DF. Neurosurg Clin N Am. 2015 Jul;26(3):389-401. doi: 10.1016/j.nec.2015.03.004. Epub 2015 May 7. Review. PMID: 26141358
Learn MoreRole of Endoscopic Skull Base and Keyhole Surgery for Pituitary and Parasellar Tumors Impacting Vision
Kelly DF, Griffiths CF, Takasumi Y, Rhee J, Barkhoudarian G, Krauss HR. J Neuroophthalmol. 2015 Dec;35(4):335-41. PMID: 26576016
Learn MoreImpact of selective pituitary gland incision or resection on hormonal function after adenoma or cyst resection.
Barkhoudarian G, Cutler AR, Yost S, Lobo B, Eisenberg A, Kelly DF. Pituitary. 2015 Jun 27.
PMID: 26115709
Predictors of sinonasal quality of life and nasal morbidity after fully endoscopic transsphenoidal surgery.
Little AS, Kelly D, Milligan J, Griffiths C, Prevedello DM, Carrau RL, Rosseau G, Barkhoudarian G, Otto BA, Jahnke H, Chaloner C, Jelinek KL, Chapple K, White WL. J Neurosurg. 2015 Jun; Epub 2015 Apr 3. PMID: 25839931
Learn MoreComparison of sinonasal quality of life and health status in patients undergoing microscopic and endoscopic transsphenoidal surgery for pituitary lesions: a prospective cohort study.
Little AS, Kelly DF, Milligan J, Griffiths C, Prevedello DM, Carrau RL, Rosseau G, Barkhoudarian G, Jahnke H, Chaloner C, Jelinek KL, Chapple K, White WL. J Neurosurg. 2015 Apr 17, PMID: 25884256
Learn MoreThe expanding role of the endonasal endoscopic approach in pituitary and skull base surgery: A 2014 perspective.
Lobo B, Heng A, Barkhoudarian G, Griffiths CF, Kelly DF. Surg Neurol Int. 2015 May 20; Review. PMID: 26015870
Learn MoreEvolution of minimally invasive approaches to the sella and parasellar region.
Louis RG, Eisenberg A, Barkhoudarian G, Griffiths C, Kelly DF. Int Arch Otorhinolaryngol. 2014 Oct; PMID: 25992138
Learn MoreThe value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery.
McLaughlin N, Eisenberg A, Cohan P, Chaloner C, Kelly DF. J Neurosurgery. 2013 Mar; 118(3):613-20.
Learn MoreNeuronavigation in endonasal pituitary and skull base surgery using an autoregistration mask without head fixation: an assessment of accuracy and practicality.
McLaughlin N, Carrau, RL, Kassam AB, Kelly DF. J Neurol Surg A Cent Eur Neurosurg. 2012 Nov;73(6):351-7.
Learn MorePituitary Centers of Excellence
McLaughlin N, Laws ER, Oyesiku NM, Katznelson L, Kelly DF. Neurosurgery. 2012 Aug 16. [Epub ahead of print]
Learn MoreEarly morning cortisol levels as predictors of short and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke’s cleft cysts.
McLaughlin N, Cohan P, Barnett P, Eisenberg A, Chaloner C, Kelly DF. World Neurosurg. 2012 Aug 14. [Epub ahead of print]
Learn MoreEndonasal management of sellar arachnoid cysts: simple cyst obliteration technique.
McLaughlin N, Vandergrift A, Ditzel Filho LF, Shahlaie K, Eisenberg AA, Carrau RL, Cohan P, Kelly DF. J Neurosurg. 2012 Apr;116(4):728-40.
Learn MoreManagement of Cushing’s disease after failed surgery–a review.
McLaughlin N, Kassam AB, Prevedello DM, Kelly DF. Can J Neurol Sci. 2011 Jan;38(1):12-21.
Learn MoreThe role of outcomes data for assessing the expertise of a pituitary surgeon.
Shahlaie K, McLaughlin N, Kassam AB, Kelly DF. Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):369-76.
Learn MoreEndonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas.
de Paiva Neto MA, Vandergrift A, Fatemi N, Gorgulho AA, Desalles AA, Cohan P, Wang C, Swerdloff R, Kelly DF. Clin Endocrinol (Oxf). 2010 Apr;72(4):512-9.
Learn MoreEndonasal vs supraorbital keyhole removal of craniopharyngiomas and tuberculum sellae meningiomas.
Fatemi N, Dusick JR, de Paiva Neto MA, Malkasian D, Kelly DF. Neurosurgery. 2009 May;64(5 Suppl 2):269-84; discussion 284-6.
Learn MorePituitary function after endonasal surgery for nonadenomatous parasellar tumors: Rathke’s cleft cysts, craniopharyngiomas, and meningiomas.
Dusick JR, Fatemi N, Mattozo C, McArthur D, Cohan P, Wang C, Swerdloff RS, Kelly DF. Surg Neurol. 2008 Nov;70(5):482-90; discussion 490-1.
Learn MoreThe endonasal microscopic approach for pituitary adenomas and other parasellar tumors: a 10-year experience.
Fatemi N, Dusick JR, de Paiva Neto MA, Kelly DF. Neurosurgery. 2008 Oct;63(4 Suppl 2):244-56; discussion 256.
Learn MorePituitary hormonal loss and recovery after transsphenoidal adenoma removal.
Fatemi N, Dusick JR, Mattozo C, McArthur DL, Cohan P, Boscardin J, Wang C, Swerdloff RS, Kelly DF. Neurosurgery. 2008 Oct;63(4):709-18; discussion 718-9.
Learn MoreEndonasal microscopic removal of clival chordomas.
Fatemi N, Dusick JR, Gorgulho AA, Mattozo CA, Moftakhar P, De Salles AA, Kelly DF. Surg Neurol. 2008 Apr;69(4):331-8.
Learn MoreThe role of the endoscope in the transsphenoidal management of cystic lesions of the sellar region.
Cavallo LM, Prevedello D, Esposito F, Laws ER Jr, Dusick JR, Messina A, Jane JA Jr, Kelly DF, Cappabianca P. Neurosurg Rev. 2008 Jan;31(1):55-64; discussion 64.
Learn MoreAvoidance of carotid artery injuries in transsphenoidal surgery with the Doppler probe and micro-hook blades.
Dusick JR, Esposito F, Malkasian D, Kelly DF. Neurosurgery. 2007 Apr;60(4 Suppl 2):322-8; discussion 328-9.
Learn MoreGraded repair of cranial base defects and cerebrospinal fluid leaks in transsphenoidal surgery.
Esposito F, Dusick JR, Fatemi N, Kelly DF. Neurosurgery. 2007 Apr;60(4 Suppl 2):295-303; discussion 303-4.
Learn MoreTranssphenoidal surgery for Cushing’s disease: a review of success rates, remission predictors, management of failed surgery, and Nelson’s Syndrome.
Kelly DF. Neurosurg Focus. 2007;23(3):E5.
Learn MoreSuboptimal sphenoid and sellar exposure: a consistent finding in patients treated with repeat transsphenoidal surgery for residual endocrine-inactive macroadenomas.
Mattozo CA, Dusick JR, Esposito F, Mora H, Cohan P, Malkasian D, Kelly DF. Neurosurgery. 2006 May;58(5):857-65; discussion 857-65.
Learn MoreDiffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging
White NS, McDonald C, Farid N, Kuperman J, Karow D, Schenker-Ahmed NM, Bartsch H, Rakow-Penner R, Holland D, Shabaik A, Bjørnerud A, Hope T, Hattangadi-Gluth J, Liss M, Parsons JK, Chen CC, Raman S, Margolis D, Reiter RE, Marks L, Kesari S, Mundt AJ, Kane CJ, Carter BS, Bradley WG, Dale AM. Cancer Res. 2014 Sep 1;74(17):4638-52.
Learn MoreCombining diffusion and perfusion differentiates tumor from bevacizumab-related imaging abnormality
Farid N, Almeida-Freitas DB, White NS, McDonald CR, Kuperman JM, Almutairi AA, Muller KA, VandenBerg SR, Kesari S, Dale AM. J Neurooncol. 2014 Dec;120(3):539-46.
Learn MoreEndonasal Endoscopic Management of Parasellar and Cavernous Sinus Meningiomas
Lobo B, Zhang X, Barkhoudarian G, Griffiths CF, Kelly DF. Neurosurg Clin N Am. 2015 Jul;26(3):389-401. doi: 10.1016/j.nec.2015.03.004. Epub 2015 May 7. Review. PMID: 26141358
Learn MoreRole of Endoscopic Skull Base and Keyhole Surgery for Pituitary and Parasellar Tumors Impacting Vision
Kelly DF, Griffiths CF, Takasumi Y, Rhee J, Barkhoudarian G, Krauss HR. J Neuroophthalmol. 2015 Dec;35(4):335-41. PMID: 26576016
Learn MoreEndoscopic and Gravity-Assisted Resection of Medial Temporo-occipital Lesions Through a Supracerebellar Transtentorial Approach: Technical Notes With Case Illustrations
Villanueva P, Louis RG, Cutler AR, Wei H, Sale D, Duong HT, Barkhoudarian G, Kelly DF. Neurosurgery. 2015 Aug 14. PMID: 26280113
Learn MoreThe expanding role of the endonasal endoscopic approach in pituitary and skull base surgery: A 2014 perspective.
Lobo B, Heng A, Barkhoudarian G, Griffiths CF, Kelly DF. Surg Neurol Int. 2015 May 20; Review. PMID: 26015870
Learn MoreEvolution of minimally invasive approaches to the sella and parasellar region.
Louis RG, Eisenberg A, Barkhoudarian G, Griffiths C, Kelly DF. Int Arch Otorhinolaryngol. 2014 Oct; PMID: 25992138
Learn MoreSupraorbital Eyebrow Craniotomy for Removal of Intraaxial Frontal Brain Tumors.
Ditzel Filho LF, McLaughlin N, Bresson D, Solari D, Kassam AB, Kelly DF.: A Technical Note. World Neurosurg. 2013 Jan 23. [Epub ahead of print]
Learn MoreThe Supraorbital Endoscopic Approach for Tumors
Wilson DA, Duong H, Teo C, Kelly DF. World Neurosurg. 2013 Feb 5. [Epub ahead of print]
Learn MoreThe value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery.
McLaughlin N, Eisenberg A, Cohan P, Chaloner C, Kelly DF. J Neurosurgery. 2013 Mar; 118(3):613-20.
Learn MoreNeuronavigation in endonasal pituitary and skull base surgery using an autoregistration mask without head fixation: an assessment of accuracy and practicality.
McLaughlin N, Carrau, RL, Kassam AB, Kelly DF. J Neurol Surg A Cent Eur Neurosurg. 2012 Nov;73(6):351-7.
Learn MoreThe supraorbital approach for recurrent or residual suprasellar tumors.
McLaughlin N, Ditzel Filho LF, Shahlaie K, Solari D, Kassam AB, Kelly DF. Minim Invasive Neurosurg. 2011 Aug;54(4):155-61.
Learn MoreEndonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas.
de Paiva Neto MA, Vandergrift A, Fatemi N, Gorgulho AA, Desalles AA, Cohan P, Wang C, Swerdloff R, Kelly DF. Clin Endocrinol (Oxf). 2010 Apr;72(4):512-9.
Learn MoreEndonasal vs supraorbital keyhole removal of craniopharyngiomas and tuberculum sellae meningiomas.
Fatemi N, Dusick JR, de Paiva Neto MA, Malkasian D, Kelly DF. Neurosurgery. 2009 May;64(5 Suppl 2):269-84; discussion 284-6.
Learn MoreAvoidance of carotid artery injuries in transsphenoidal surgery with the Doppler probe and micro-hook blades.
Dusick JR, Esposito F, Malkasian D, Kelly DF. Neurosurgery. 2007 Apr;60(4 Suppl 2):322-8; discussion 328-9.
Learn MoreGraded repair of cranial base defects and cerebrospinal fluid leaks in transsphenoidal surgery.
Esposito F, Dusick JR, Fatemi N, Kelly DF. Neurosurgery. 2007 Apr;60(4 Suppl 2):295-303; discussion 303-4.
Learn MoreEndonasal transsphenoidal surgery and multimodality treatment for giant pituitary adenomas
de Paiva Neto MA, Vandergrift A, Fatemi N, Gorgulho AA, Desalles AA, Cohan P, Wang C, Swerdloff R, Kelly DF. Clin Endocrinol (Oxf). 2010 Apr;72(4):512-9.
Learn MoreMolecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology
Patel SP, Schwaederle M, Daniels GA, Fanta PT, Schwab RB, Shimabukuro KA, Kesari S, Piccioni DE, Bazhenova LA, Helsten TL, Lippman SM, Parker BA, Kurzrock R. Oncotarget. 2015 Oct 20;6(32):32602-9.
Learn MoreNext generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancer
Schwaederle M, Daniels GA, Piccioni DE, Kesari S, Fanta PT, Schwab RB, Shimabukuro KA, Parker BA, Kurzrock R. Cell Cycle. 2015;14(11):1730-7.
Learn More
